The anti-FAP CAR-T cells effectively eliminated stromal cells and depleted the immunosuppressive matrix, and subsequent treatment with anti-MSLN CAR-T cells led to improved tumor control, suggesting that stromal depletion sensitized the tumor to treatment with the anti-MSLN CAR-T cells. This evidence concerns the gene MSLN and neoplasm.